Abstract
Although radiography is a first-line test for the assessment of bone lesions, MR imaging is needed for defining the extent of a bone tumor. In addition, MR imaging provides features and metrics for the characterization of bone lesions as well as for the evaluation a tumor following treatment. There are several noncontrast and contrast-enhanced sequences available for clinical use that collectively provide valuable information for tumor evaluation, and include conventional T1-weighted imaging, fluid-sensitive sequences, chemical shift imaging, and diffusion-weighted imaging with ADC mapping, as well as postcontrast sequences, including static postcontrast imaging and dynamic contrast-enhanced MR imaging.
Original language | English (US) |
---|---|
Pages (from-to) | 559-569 |
Number of pages | 11 |
Journal | Magnetic Resonance Imaging Clinics of North America |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - Nov 1 2018 |
Keywords
- Bone neoplasm
- Chemical shift imaging
- DCE-MR imaging
- DWI
- MR imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging